[HTML][HTML] MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis

JY Ho, RJ Hsu, JM Liu, SC Chen, GS Liao, HW Gao… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Aberrant activation of the Ras/ERK pathway mediates breast cancer initiation and
aggressiveness. Therefore, it is important to identify miRNAs that modulate the Ras/ERK …

[HTML][HTML] Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2

JY Ho, RJ Hsu, CH Wu, GS Liao, HW Gao, TH Wang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Hyperactivation of the Ras/ERK pathway contributes to breast cancer initiation and
progression, and recent evidence suggests aberrant signaling of miRNAs that regulate the …

[PDF][PDF] RETRACTED: MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway

Z Ghaemi, BM Soltani, SJ Mowla - Frontiers in oncology, 2019 - frontiersin.org
Breast cancer represents the most common malignancy in women worldwide and the
ErbB/PI3K pathway has been found to play a crucial role in regulation of the cancer cell …

miR‑532‑5p promotes breast cancer proliferation and migration by targeting RERG

L Huang, X Tang, X Shi, L Su - Experimental and …, 2020 - spandidos-publications.com
Aberrant expression of microRNAs (miRNAs/miRs) mediates the initiation and progression
of breast cancer. Therefore, it is important to investigate the molecular mechanisms of …

miR-331-3p suppresses cell proliferation in TNBC cells by downregulating NRP2

M Zhao, M Zhang, Z Tao, J Cao… - Technology in Cancer …, 2020 - journals.sagepub.com
Purpose: Triple-negative breast cancer is characterized by fast progression with high
possible for metastasis and poor survival. Dysfunction of microRNAs plays an important role …

MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells

Y Zhao, Y Li, G Lou, L Zhao, Z Xu, Y Zhang, F He - PloS one, 2012 - journals.plos.org
ERRα is an orphan nuclear receptor emerging as a novel biomarker of breast cancer. Over-
expression of ERRα in breast tumor is considered as a prognostic factor of poor clinical …

MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer

J Zhang, X Kong, Q Shi, B Zhao - Cancer Biomarkers, 2020 - content.iospress.com
BACKGROUND: MicroRNAs (miRNAs) have been reported to serve as potential biomarkers
in various cancer and play important roles in tumor progression. OBJECTIVE: The aim of this …

Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer

P Li, J Dong, X Zhou, W Sun, H Huang… - OncoTargets and …, 2017 - Taylor & Francis
This study was aimed to assess the expression and clinical performance of microRNA-329
(miR-329) in breast cancer. We recruited 134 breast cancer patients and 70 healthy …

MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK

P Chen, W Xu, Y Luo, Y Zhang, Y He… - OncoTargets and …, 2017 - Taylor & Francis
Background Breast cancer affects millions of people with a high mortality rate throughout the
world; microRNA 543 (miR-543) has been reported to suppress progression in some kinds …

Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7

Y Tang, S Yang, M Wang, D Liu… - International …, 2019 - spandidos-publications.com
Emerging evidence has demonstrated that microRNAs (miRNAs/miRs) have various
biological functions in the development of human epidermal growth factor receptor 2 (HER2) …